Intraperitoneal and intraamygdala N(6)-cyclohexyladenosine suppress hippocampal kindled seizures in rats

Brain Res. 2000 Mar 6;858(1):48-54. doi: 10.1016/s0006-8993(99)02425-7.

Abstract

Effects of intraperitoneal and intraamygdala N(6)-cyclohexyladenosine (CHA), a selective adenosine A(1) receptor agonist, and 1,3-dimethyl-8-cyclopentylxanthine (CPT), a selective adenosine A(1) receptor antagonist, were examined in fully hippocampal kindled rats. Intraperitoneal administration of CHA (0. 25, 0.5 and 1 mg/kg) decreased hippocampal secondary afterdischarge duration (SAD) and amygdala afterdischarge duration (ADD). Only the 1 mg/kg dose induced a significant increase in latency to stage 4. Intraperitoneal administration of CPT (0.25, 0.5 and 1 mg/kg) induced a significant increase in stage 5 duration, hippocampal SAD and ADD. Pretreatment of animals with CPT (1 mg/kg), antagonized effects of CHA on seizure parameters. Intraamygdala microinfusion (1 microl over 2 min) of CHA (5 nM-1 mM) significantly reduced hippocampal SAD and amygdala ADD. These effects were antagonized by intraamygdala CPT (1 microM). Results obtained suggest that in hippocampal kindled rats, amygdala may be regarded as a relay point for AD propagation specially in recruit activity of the hippocampus.

MeSH terms

  • Adenosine / administration & dosage
  • Adenosine / analogs & derivatives*
  • Adenosine / antagonists & inhibitors
  • Amygdala / drug effects*
  • Amygdala / physiopathology
  • Animals
  • Anticonvulsants / administration & dosage*
  • Behavior, Animal / drug effects
  • Dose-Response Relationship, Drug
  • Drug Antagonism
  • Electric Stimulation
  • Hippocampus / drug effects*
  • Hippocampus / physiopathology
  • Injections, Intraperitoneal
  • Kindling, Neurologic / drug effects*
  • Male
  • Microinjections
  • Purinergic P1 Receptor Agonists
  • Purinergic P1 Receptor Antagonists
  • Rats
  • Rats, Sprague-Dawley
  • Reaction Time / drug effects
  • Seizures / prevention & control*
  • Xanthines / administration & dosage

Substances

  • 1,3-dimethyl-8-cyclopentylxanthine
  • Anticonvulsants
  • Purinergic P1 Receptor Agonists
  • Purinergic P1 Receptor Antagonists
  • Xanthines
  • N(6)-cyclohexyladenosine
  • Adenosine